David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
PUT
AMC Entertainment Holdings
AMC
$2.44B
| $1.86M | ﹤0.01% |
12,660
+7,010
| +124% | +$1.17M |
|
2052
PUT
BioMarin Pharmaceuticals
BMRN
$12.8B
| $1.86M | ﹤0.01% |
20,000
| – | – |
|
|
XCRA
2053
DELISTED
Xcerra Corporation
XCRA
| $1.86M | ﹤0.01% |
188,681
+119,771
| +174% | +$1.16M |
|
|
REV
2054
PUT
DELISTED
Revlon, Inc.
REV
| $1.86M | ﹤0.01% |
75,600
+30,000
| +66% | +$580K |
|
2055
Amphenol
APH
$198B
| $1.85M | ﹤0.01% |
87,576
+14,088
| +19% | +$277K |
|
|
PGEM
2056
DELISTED
Ply Gem Holdings, Inc.
PGEM
| $1.85M | ﹤0.01% |
108,547
+1,503
| +1% | +$24.7K |
|
|
GNBC
2057
DELISTED
Green Bancorp, Inc
GNBC
| $1.85M | ﹤0.01% |
78,041
+49,117
| +170% | +$1.05M |
|
2058
CALL
MarketAxess Holdings
MKTX
$5.72B
| $1.84M | ﹤0.01% |
10,000
-10,000
| -50% | -$1.91M |
|
|
2059
PUT
MarketAxess Holdings
MKTX
$5.72B
| $1.84M | ﹤0.01% |
10,000
| – | – |
|
2060
CALL
KeyCorp
KEY
$23.6B
| $1.84M | ﹤0.01% |
97,800
| – | – |
|
|
JOBS
2061
DELISTED
51job Inc
JOBS
| $1.84M | ﹤0.01% |
30,317
+24,905
| +460% | +$1.36M |
|
2062
CALL
Phillips 66
PSX
$95.7B
| $1.83M | ﹤0.01% |
20,000
| – | – |
|
|
IPG
2063
DELISTED
Interpublic Group of Companies
IPG
| $1.83M | ﹤0.01% |
88,041
+1,448
| +2% | +$31.5K |
|
|
BOLD
2064
DELISTED
Audentes Therapeutics, Inc
BOLD
| $1.83M | ﹤0.01% |
65,352
-2,174
| -3% | -$47.2K |
|
|
SWN
2065
PUT
DELISTED
Southwestern Energy Company
SWN
| $1.83M | ﹤0.01% |
299,300
-300,900
| -50% | -$1.71M |
|
2066
Mueller Water Products
MWA
$3.92B
| $1.83M | ﹤0.01% |
142,691
+96,626
| +210% | +$1.15M |
|
|
KRA
2067
DELISTED
Kraton Corporation
KRA
| $1.83M | ﹤0.01% |
45,144
+21,626
| +92% | +$747K |
|
2068
Peapack-Gladstone Financial
PGC
$804M
| $1.82M | ﹤0.01% |
54,091
-577
| -1% | -$18.2K |
|
|
CCXI
2069
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.82M | ﹤0.01% |
245,635
+4,071
| +2% | +$33.8K |
|
2070
PUT
Gartner
IT
$12.2B
| $1.82M | ﹤0.01% |
+14,600
| New | +$1.8M |
|
2071
PUT
Grand Canyon Education
LOPE
$3.89B
| $1.82M | ﹤0.01% |
20,000
| – | – |
|
2072
Allegiant Air
ALGT
$2.29B
| $1.8M | ﹤0.01% |
13,706
-34,560
| -72% | -$4.45M |
|
2073
Coty
COTY
$2.37B
| $1.8M | ﹤0.01% |
+109,077
| New | +$1.97M |
|
2074
CALL
Twilio
TWLO
$34.6B
| $1.8M | ﹤0.01% |
+60,200
| New | +$1.8M |
|
|
KW
2075
DELISTED
Kennedy-Wilson Holdings
KW
| $1.79M | ﹤0.01% |
96,592
-42,111
| -30% | -$812K |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.